Client Success: Commercial Assessment for Crossover Investor-Funded Private Biotech
![](https://rnaadvisors.com/wp-content/uploads/2016/10/iStock-617382644.jpg)
THE PROBLEM: Novel technology platform could be used across a wide range of rare diseases, so executive team and board want an independent, evidence-based view of commercial opportunity to complement the scientific analysis. THE SOLUTION: Interviews with KOL physician-scientists to understand unmet need and applicability of technology to targets, detailed pipeline analysis, market modeling and […]
Client Success: Valuation Support for Licensing Transaction – Novel Cancer Therapy
![](https://rnaadvisors.com/wp-content/uploads/2016/08/iStock-910730068.jpg)
THE PROBLEM: Publicly traded late-stage therapeutics company negotiates with, and enters into, collaboration / license arrangement with a big pharma partner. THE SOLUTION: Forecasting, market research, modeling and transaction support combined with resultant collaboration agreement accounting analyses. “You were a great support for us, responsive and knowledgeable. Thank you!” CFO “You are my top go […]
Client Success: Portfolio Valuation for LPs of $1B + Healthcare-Focused PE Firm
![](https://rnaadvisors.com/wp-content/uploads/2016/08/Valuation_Advisory_2.jpeg)
THE PROBLEM: Two of the largest pension funds in the world required an independent valuation assessment of the portfolio of a multi-billion dollar life science/ healthcare private equity fund. THE SOLUTION: Robust research, forecasting, modeling, comp analysis and valuation analytics to determine reasonableness of value indications. “We love working with you. You actually know what […]